View in EDS

Novel Approach to Pre-Exposure Prophylaxis (PrEP) of COVID-19: Development of S-892216 Long-Acting Injectable Suspension.

Saved in:
Bibliographic Details
Title: Novel Approach to Pre-Exposure Prophylaxis (PrEP) of COVID-19: Development of S-892216 Long-Acting Injectable Suspension.
Authors: Ohashi R; Formulation R&D Laboratory, Pharmaceutical Technology Research Division, Shionogi & Co., Ltd., 2-1-3 Kuise Terajima, Amagasaki, Hyogo 660-0813, Japan., Watari R; Laboratory for Drug Discovery and Development, Shionogi & Co., Ltd., 3-1-1 Futaba-cho, Toyonaka, Osaka 561-0825, Japan., Kondo D; Formulation R&D Laboratory, Pharmaceutical Technology Research Division, Shionogi & Co., Ltd., 2-1-3 Kuise Terajima, Amagasaki, Hyogo 660-0813, Japan., Otake S; Formulation R&D Laboratory, Pharmaceutical Technology Research Division, Shionogi & Co., Ltd., 2-1-3 Kuise Terajima, Amagasaki, Hyogo 660-0813, Japan., Murata T; Formulation R&D Laboratory, Pharmaceutical Technology Research Division, Shionogi & Co., Ltd., 2-1-3 Kuise Terajima, Amagasaki, Hyogo 660-0813, Japan., Kimura G; Formulation R&D Laboratory, Pharmaceutical Technology Research Division, Shionogi & Co., Ltd., 2-1-3 Kuise Terajima, Amagasaki, Hyogo 660-0813, Japan.
Source: Chemical & pharmaceutical bulletin [Chem Pharm Bull (Tokyo)] 2025; Vol. 73 (8), pp. 670-677.
Publication Type: Journal Article
Journal Info: Publisher: Pharmaceutical Society of Japan Country of Publication: Japan NLM ID: 0377775 Publication Model: Print Cited Medium: Internet ISSN: 1347-5223 (Electronic) Linking ISSN: 00092363 NLM ISO Abbreviation: Chem Pharm Bull (Tokyo) Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40790509
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Novel Approach to Pre-Exposure Prophylaxis (PrEP) of COVID-19: Development of S-892216 Long-Acting Injectable Suspension.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ohashi+R%22">Ohashi R</searchLink>; Formulation R&D Laboratory, Pharmaceutical Technology Research Division, Shionogi & Co., Ltd., 2-1-3 Kuise Terajima, Amagasaki, Hyogo 660-0813, Japan.<br /><searchLink fieldCode="AU" term="%22Watari+R%22">Watari R</searchLink>; Laboratory for Drug Discovery and Development, Shionogi & Co., Ltd., 3-1-1 Futaba-cho, Toyonaka, Osaka 561-0825, Japan.<br /><searchLink fieldCode="AU" term="%22Kondo+D%22">Kondo D</searchLink>; Formulation R&D Laboratory, Pharmaceutical Technology Research Division, Shionogi & Co., Ltd., 2-1-3 Kuise Terajima, Amagasaki, Hyogo 660-0813, Japan.<br /><searchLink fieldCode="AU" term="%22Otake+S%22">Otake S</searchLink>; Formulation R&D Laboratory, Pharmaceutical Technology Research Division, Shionogi & Co., Ltd., 2-1-3 Kuise Terajima, Amagasaki, Hyogo 660-0813, Japan.<br /><searchLink fieldCode="AU" term="%22Murata+T%22">Murata T</searchLink>; Formulation R&D Laboratory, Pharmaceutical Technology Research Division, Shionogi & Co., Ltd., 2-1-3 Kuise Terajima, Amagasaki, Hyogo 660-0813, Japan.<br /><searchLink fieldCode="AU" term="%22Kimura+G%22">Kimura G</searchLink>; Formulation R&D Laboratory, Pharmaceutical Technology Research Division, Shionogi & Co., Ltd., 2-1-3 Kuise Terajima, Amagasaki, Hyogo 660-0813, Japan.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220377775%22">Chemical & pharmaceutical bulletin</searchLink> [Chem Pharm Bull (Tokyo)] 2025; Vol. 73 (8), pp. 670-677.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Pharmaceutical+Society+of+Japan%22">Pharmaceutical Society of Japan </searchLink><i>Country of Publication: </i>Japan <i>NLM ID: </i>0377775 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1347-5223 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200092363%22">00092363 </searchLink><i>NLM ISO Abbreviation: </i>Chem Pharm Bull (Tokyo) <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40790509
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1248/cpb.c25-00198
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 670
    Titles:
      – TitleFull: Novel Approach to Pre-Exposure Prophylaxis (PrEP) of COVID-19: Development of S-892216 Long-Acting Injectable Suspension.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ohashi R
      – PersonEntity:
          Name:
            NameFull: Watari R
      – PersonEntity:
          Name:
            NameFull: Kondo D
      – PersonEntity:
          Name:
            NameFull: Otake S
      – PersonEntity:
          Name:
            NameFull: Murata T
      – PersonEntity:
          Name:
            NameFull: Kimura G
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2025
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1347-5223
          Numbering:
            – Type: volume
              Value: 73
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Chemical & pharmaceutical bulletin
              Type: main
ResultId 1